Skip to main content

Featured

U.S. Journalist Abducted in Baghdad Amid Rising Security Fears

                                   FILE PHOTO: An aerial view of Baghdad An American journalist was kidnapped in central Baghdad, according to Iraqi police officials who reported the incident early Tuesday. The abduction occurred near a busy commercial district where foreign media workers often travel, underscoring ongoing concerns about the safety of international personnel operating in the region. Witnesses told authorities that armed men intercepted the journalist’s vehicle and forced them into another car before speeding away. Police have launched an investigation and are coordinating with federal security forces to track the kidnappers and determine the journalist’s whereabouts. No group has yet claimed responsibility, but officials say the method of the abduction resembles tactics used by organized militias and criminal networks active in the capital. U.S. diplomatic represe...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments